Edwards Lifesciences Corp.

NYS : EW
Pharmaceuticals
Irvine CA
Revenue (US$ Millions)$2,323
Revenue Growth (%)13.56%
Net Income (Millions)$811
Common Shares Outstanding (Millions)$108
Earnings per Share$7.48
Price To Earnings Ratio17.52
Total Equity (Millions)$2,191
Profit Margin 134.92%
Return on Equity52.02%
Long Term Debt (US$ Millions)$598
Debt To Equity Ratio (%)0.27%
Market Capitalization (US$ Millions)$13,732
Total Assets (US$ Millions)$3,524
Return on Assets (%)29.77
Current Assets (US$ Millions)$2,295
Inventories (US$ Millions)$297
Current Liabilities (US$ Millions)$434
Cost of Goods Sold (US$ Millions)$626
Asset Turnover0.66
Inventory Turnover2.07